• Mylan Recalls Three Lots of Nizatidine Capsules americanpharmaceuticalreview
    January 14, 2020
    Mylan announced its U.S. based Mylan Pharmaceuticals business is conducting a voluntary nationwide recall, to the consumer level, of three lots of Nizatidine Capsules, USP (including the 150mg and 300mg strengths).
PharmaSources Customer Service